Abstract-Four uterine-contractile substances (a, b, c and d) were extracted from procedures with acetic acid, n-butanol, distilled water, and methanol from the reaction mixture obtained by incubating rat plasma kininogen with the kininforming enzyme in the rat stomach. Gradient and equilibrium chromatography on SP-Sephadex C-25 columns were carried out with the extract containing these materials (a, b, c and d). The materials could not be separated by chromatography on SP-Sephadex C-25, but were separated by high performance liquid chromatography (HPLC) with a Zorbax ODS reversed-phase column. All the materials (a, b, c and d) contracted the rat uterus and relaxed the rat duodenum. The uterine-contractile activity of the materials was abolished by chymotrypsin, but not by trypsin treat ment. The retention times of materials a, c and d on H PLC were different from that of kallidin, MLBK, bradykinin (BK) and neurotensin; but the retention time of material b was equal to that of BK.
In a previous paper, we reported that the kinin-forming enzyme (KFE), which has a pH optimum of 4.8, existed in the rat stomach (1) . We showed that KFE had characteristics that were similar to those of cathepsin D (2) . The subtance from rat plasma produced by KFE was classified as a biologically brady kinin (BK)-like substance (1) . This report describes the isolation, purification, and identification of the BK-like substance generated by KFE.
MATERIALS AND METHODS
Preparation of kinin-forming enzyme and kininogen: Kinin-forming enzyme from rat stomach (KFE) and kininogen of rat plasma (KGN) were prepared by the method described previously (2) . Generation of kinins from KGN by KFE: The incubation was carried out using a mixture of 140 ml of KGN solution (50 mg/ ml) dissolved in 0.05 M phosphate buffer (pH 4.8) and 140 ml of the KFE preparation (5 mg/ml) dissolved in the same buffer for 16 hr at 37'C. The reaction was terminated by boiling for 5 min. A part of the resultant solution was adjusted to pH 8.0 with 3 N NaOH and assayed with the isolated rat uterus.
Extraction procedure: The reaction mixture containing uterine-contractile activity, ob tained from the incubation described above, was extracted according to the method described previously (3) . The reaction mixture (240 ml) was adjusted to pH 2.0 with 3 N HCI and saturated with NaCl. After addition of an equal volume of n-butanol, the mixture was shaken for 10 min and centrifuged at 700 g for 10 min. The n-butanol phase was pipetted to another tube. The extraction with n-butanol was then repeated. After addition of 10 g of anhydrous sodium sulfate per 40 ml of the combined n-butanol phase, the solution was stored overnight at -20°C. After centri fugation at 700 g for 10 min, the supernatant fraction was transferred to another tube and 2 volume of petroleum ether were added. The mixture was extracted with a one tenth volume of distilled water by shaking for 10 min, centrifuged at 700 g for 10 min, and the aqueous phase was pipetted to another tube. The extraction with distilled water was repeated. The combined aqueous phase was adjusted to pH 7.0 with 1 N NaOH and evaporated to dryness at below 35'C. The dried residue was extracted twice with 240 ml of methanol by shaking for 10 min. After centrifugation at 700 g for 10 min, the supernatant fraction was evaporated to dry ness at below 35°C. The dried residue was chromatographed on SP-Sephadex C-25. Chromatography on SP-Sephadex C-25: The preparation containing uterine-con tractile activity (800 i g BK equivalent on assay with the isolated rat uterus in the presence of atropine and dibenamine), obtained from the extraction procedure, was dissolved in 300 ml of distilled water and submitted to gradient chromatography on a SP-Sephadex C-25 column, 2.5x46 cm, by the method described previously (3). The column resin was suspended in 0.5 M ammonium formate for 24 hr and washed with distilled water before use. The pre paration dissolved in distilled water described above was applied to the column; the column was washed with 500 ml of distilled water and then developed with a linear gradient of ammonium formate solution, pH 5.4 (0 0.4 M). The fractions of 20 ml each were collected, lyophilized, and a part of each dried residue was dissolved in 0.9% saline. The resultant solution was assayed with the isolated rat uterus.
The lyophilized preparation containing uteri ne-contractile activity, obtained from the gradient chromatography, and standard materials were dissolved in 0.05 M Tris-HCI Buffer, pH 8.0, containing 0.08 M NaCI. The resultant solutions were submitted to equilibrium chromatography on a SP Sephadex C-25 column, 1.3x14 cm, by the method described previously (3). Fractions of 6 ml each were collected and assayed with the isolated rat uterus.
The fractions containing uterine-contractile activity, obtained from the equilibrium chro matography, were pooled and submitted to gradient chromatography as described above for desalting.
Gel chromatography: The preparation con taining uterine-contractile activity (600 t g BK equivalent), obtained from chromato graphy on SP-Sephadex C-25, was dissolved in 0.2 N acetic acid and chromatographed on a Sephadex G-25 column, 2.6x89 cm. The flow rate was 14 ml/hr. The fractions of 10 ml each were collected, lyophilized, and a part of each fraction was dissolved in 0.9% saline. The resultant solutions were tested with the isolated rat uterus.
For estimation of the molecular weight of the test material, a 0.9x97 cm column of Sephadex G-25 (suspended in 0.2 N acetic acid) was utilized. The flow rate was 7.0 ml/ hr. Fractions of 2.0 ml each were collected and tested with the isolated rat uterus according to the same method described above. The following substances were used as standard materials: kallidin, neurotensin and Ieu5-enkephalin.
The above two columns were also utilized for desalting after high performance liquid chromatography (HPLC).
High voltage paper electrophoresis (HVPE): HVPE was performed on Whatman No. 1 filter paper (Whatman Ltd., England) using a Model H PE-V electrophoresis ap paratus (Toyo Kagaku Sangyo Co., Ltd., Osaka, Japan) at 50 volts per cm with n hexane as an inert cooling medium. The buffer used in this study consisted of 0.6 N formic acid-2 N acetic acid (1 :1), pH 1.9. Densitometry was carried out with a Model CS-910 dual wave-length TLC scanner (Shimadzu Scientific Instruments, Inc., Kyoto, Japan).
HPLC: A Model LC-3A high performance liquid chromatography (Shimadzu Scientific Instruments, Inc., Kyoto, Japan) with a Model UVIDEC 100-III ultraviolet spectro photometer (Japan Spectroscopic Co., Ltd. (JASCO), Tokyo, Japan) and a Model SIL 1A loop injector (JASCO) were utilized. Chromatograms were recorded with a Model U-125 MN single-pen recorder (Shimadzu Scientific Instruments, Inc., Kyoto, Japan). The column used in this study was a Zorbax ODS reversed-phase column (Du Pont Instru ments, U.S.A.) of dimensions 0.46x25 cm. The mobile phase was 0.05 M potassium dihydrogen phosphate (pH 2.5)-acetonitrile (8:2). The flow rate was 0.1 ml/min, and the separation was performed at ambient temper ature. Ultraviolet detection was carried out at 220 and 280 nm. The preparation contain ing uterine-contractile activity (540 ,ig BK equivalent), obtained from gel chromato graphy, or the standard materials: kallidin, MLBK, BK and neurotensin (160 fig/ml each) were dissolved in distilled water. A 0.05 ml aliquot of each of the resultant solutions was injected into the two columns (each 25 cm long and joined in series) through a 5 cm long pre-column and eluted as described above. Fractions of 0.7 ml each were collected, adjusted to pH 7.0 with 3 N NaOH, lyophilized, and a part of each fraction was dissolved in 0.9% saline. The resultant solutions were assayed with the isolated rat uterus. The fractions containing uterine-contractile activity were combined, lyophilized and desalted by gel chromato graphy. H PLC was repeated with the desalted preparation.
Enzymatic treatment: Digestions with tryp sin and chymotrypsin were carried out by incubating 1 ml of the preparation containing the uterine-contractile activity (0.25 i g BK equivalent) with 0.2 ml of enzyme solution
(1 mg/ml in distilled water) at 37'C, pH 8.0, for 20 min. The reactions were terminated by boiling for 5 min. After centrifugation at 700 g for 10 min, the supernatant fractions were assayed with the isolated rat uterus.
Biological procedure: The bioassay was carried out by the method described previously (3) . De Jalon's solution containing atropine (10-6 g/ml) and dibenamine (10"' g/ml) was used to suspend the isolated rat uterus, and a solution containing additional diphenhydramine (10'8 g/ml) and pro pranolol (10'8 g/ml) was used to suspend the isolated rat duodenum. The blood pressure was recorded from the carotid artery of urethanized (1.5-2.0 g/kg, s.c.) rabbits. The test sample was adminis tered into the cannule tied into the vena marginalis after intravenous administration of atropine (2 mg/kg, 1 min pretreated), dibenamine (5 mg/kg, 40 min pretreated), and propranolol (0.3 mg/kg, 1 min pre treated).
Recovery: The recovery of standard BK was about 75% in the extraction step, and that in the SP-Sephadex, Sephadex G-25 and H PLC steps was about 90%.
Materials: The following reagents were used: SP-Sephadex C-25 Fine and Sephadex G-25 Fine (Pharmacia Fine Chemicals, Sweden); kallidin, MLBK, BK, neurotensin and leu5-enkephalin (Protein Research Foun dation, Osaka, Japan); trypsin from bovine pancreas Type III and chymotrypsin from bovine pancreas (Sigma Chemical Co., U.S.A.); atropine sulfate (E. Merck AG, Germany); dibenamine HCI (Nakarai Chemi cals Ltd., Kyoto, Japan); propranolol HCI (ICI Pharmaceutical Division, England): diphenhydramine HCI (Tanabe Seiyaku Co., Ltd., Osaka, Japan) and acetonitrile (Wako Pure Chemical Industries, Ltd., Osaka, Japan).
RESULTS
Generation and extraction of the uterine contractile substance: The uterine-contractile substance was generated by the incubation of KGN with KFE. Seven grams of the KGN preparation were capable of yielding 1,400 ,ag of BK equivalent on assay with the isolated rat uterus in the presence of atropine and dibenamine. The reaction mixture was sub mitted to extraction with n-butanol, distilled water and methanol. The resultant extract contracted the isolated rat uterus in the presence of atropine and dibenamine, and it relaxed the isolated rat duodenum in the additional presence of diphenhydramine and propranolol. The extract produced a fall in rabbit blood pressure after intravenous admin istration of atropine, dibenamine and pro pranolol.
Gradient chromatography on SP-Sephadex C-25: Linear gradient chromatography was carried out with the lyophilized preparation (800 ,tg BK equivalent) obtained from the extraction procedure. The uterine-contractile activity (700 ag BK equivalent) was detected in fractions No. 21 to 25 in the presence of atropine and dibenamine (Fig. 1) . These fractions also relaxed the isolated rat duodenum in the additional presence of diphenhydramine and propranolol.
Equilibrium chromatography on SP Sephadex C-25: In Fig. 2 , panel A shows the elution pattern of the preparation, obtained from gradient chromatography, assayed with the isolated rat uterus in the presence of atropine and dibenamine. Panel B shows the elution pattern of the standard materials: BK, MLBK and kallidin detected by assay with the isolated rat uterus. The retention time of the preparation differed from those of the standard materials.
Gel chromatography on Sephadex G-25: The preparation obtained from equilibrium chromatography was applied to gel chromato graphy. The uterine-contractile activity was detected in fractions No. 29 to 31 in the presence of atropine and dibenamine (Fig. 3) .
Analytical HVPE: The preparation obtained from gel chromatography was submitted to HYPE. Two peaks and one shoulder were (800 fcg BK equivalent on assay with the isolated rat uterus in the presence of 10-6 g/ml atropine and 10-7 g/ ml dibenamine) obtained from the extraction procedure was dissolved in distilled water and applied to a 2.5x46 cm SP-Sephadex C-25 column. The column was washed with 1 500 ml of distilled water and then developed with a linear gradient of ammonium formate solution, The uterine-contractile activity of the materials (a, b, c and d) contained in these regions was 0.9, 0.9, 15 and 5.6 icg BK Fig. 2 . Equilibrium chromatography of the pre paration obtained from gradient chromato graphy. The lyophilized preparation (120 Pg BK equivalent on assay with the isolated rat uterus in the presence of 10-6 g/ml atropine and 10-7 g/ml dibenamine) containing uterine contractile activity was applied to a 1.3x14 cm SP-Sephadex C-25 column. The elution buffer was 0.05 M Tris-HCI buffer (pH 8.0) containing 0.08 M NaCI. The flow rate was 6 ml/hr. Fractions of 6 ml each were collected, and a part of each fraction was tested with the isolated rat uterus in the presence of 10-6 g/ml atropine and 10-7 g/ml dibenamine. Panel A shows the elution pattern of the preparation. Panel B shows the elution pattern of the standard materials 1: BK, 2: MLBK and 3: Kallidiri (60, 400 and 300 ug, respectively). Fig. 3 . Gel chromatography of the preparation obtained from equilibrium chromatography. The preparation (3 ,tg BK equivalent on assay with the isolated rat uterus in the presence of 10-6 g/ml atropine and 10-7 g/ml dibenamine) containing uterine-contractile activity was dis solved in 0.2 N acetic acid and applied to a 2.6x89 cm Sephadex G-25 column. The flow rate was 14 ml/hr. Fractions of 10 ml each were collected, lyophilized, and a part of each fraction was dissolved in 0.9% saline. The resultant solution was assayed with the isolated rat uterus in the presence of 10-6 g/ml atropine and 10-7 g/ml dibenamine. S shows the preparation (1 ug BK equivalent on assay with the isolated rat uterus in the presence of 10-6 g/ ml atropine and 10-7 g/ml dibenamine) con taining uterine-contractile activity. The densi tometry of the ninhydrin-stained spot of S on the guide strip was carried out at 570 nm. The uterine-contractile activity was detected from the hatched area of the preparative strip in the presence of 10-6 g/ml atropine and 10-7 g/ml dibenamine. Arg indicates arginine (10 leg) used as the standard marker. Conditions: 30 min at 50 volts per cm, pH 1.9. Figure 6 shows the chromatographic The preparation (25 Pg BK equivalent as assayed with the rat uterus in the presence of 10-6 g/ml atropine and 10-7 g/ml dibenamine) containing uterine contractile activity and standard materials (8 ng each) were dissolved in distilled water, and they were applied to a Zorbax ODS reversed-phase column (two columns, each 25 cm long, joined in series). The mobile phase was 0.05 M potassium dihydrogen phosphate (pH 2.5)-acetonitrile (8:2). The flow rate was 0.1 ml/min. Ultraviolet detection was carried out at 220 and 280 nm. Fractions of 0.7 ml each were collected, adjusted to pH 7.0 with 3 N NaOH, lyophilized, and a part of each preparation was assayed with the isolated rat uterus in the presence of 10-6 g/ml atropine and 10-7 g/ml dibenamine.
Panel HPLC was repeated with the desalted preparation (5 !ig BK equivalent on assay with the isolated rat uterus in the presence of 10-6 g/ml atropine and 10-7 g/ml dibenamine) containing uterine-contractile activity obtained previously by HPLC. The sample size was 20 II. Ultraviolet detection was carried out at 220 nm (0.04 a.u.f.s.). column. The pre paration (10 eg BK equivalent on assay with the isolated rat uterus in the presence of 10-6 g/ ml atropine and 10-7 g/ml dibenamine) con taining material c was dissolved in 0.2 N acetic acid and applied to the Sephadex G-25 column. The column size was 0.9x97 cm (the void volume determined with blue dextran 2000 was 33 ml), and the flow rate was 7.0 ml/hr. Fractions of 2.0 ml each were collected and tested with the isolated rat uterus in the presence of 10-6 g/ml atropine and 10-7 g/ml dibenamine. profile, detected at 220 nm, on HPLC repeated with the region containing the major mateial c indicated in panel B of Fig. 5 . The retention time of the peak containing the uterine-contractile activity was equal to that of material c.
Estimation of molecular weight: Figure 7 shows the elution positions of material c and standard materials of known molecular weight. The apparent molecular weight of material c obtained from this plot was 1650.
Biological studies: In Fig. 8 , panels A, B and C show the effects of the preparation containing material c on the isolated rat uterus, isolated rat duodenum, and rabbit blood pressure, respectively. The preparation containing material c contracted the uterus (1.2x10-10 g/ml) in the presence of atropine and dibenamine, relaxed the duodenum (2x10-10 g/ml) in the additional presence of diphenhydramine and propranolol, and pro duced a fall in the blood pressure (4.4x10-8 g/kg) after administration of atropine, dibe namine and propranolol.
DISCUSSION
We reported the existence of KFE which has a pH optimum of 4.8 in the rat stomach (1) . The KFE content in the rat stomach was much higher than that in any region of the intestine, and the KFE had characteristics similar to cathepsin D which was distinct from gastrointestinal kallikrein and pepsin (2) . Cathepsin D occurs in a variety of tissues: Fig. 8 . Effects of the preparation containing material c obtained from rechromatography on the Zorbax ODS reversed-phase column on the isolated rat uterus and duodenum and on the rabbit blood pressure. The preparation containing material c was tested with the isolated tissues suspended in De Jalon's solution containing the following antagonists: A: uterus, atropine (10-6 g/ml) and dibenamine (10-7 g/ml); B: duodenum, additional diphenhydramine (10-8 g/ ml) and propranolol (10-8 g/ml) to A. Panel C shows the effect on the rabbit blood pressure. The blood pressure was recorded from the carotid artery of urethanized (1 .5-2.0 g/kg, s.c.) rabbits. The test samples were administered into the cannule tied to the vena marginalis after intravenous administration of atropine (2 mg/ kg, 1 min pretreated), dibenamine (5 mg/kg, 40 min pretreated) and propranolol (0.3 mg/kg, 1 min pretreated). BK indicates bradykinin as the standard material. ox spleen (4), rabbit liver (5) and chicken muscles (6). Greenbaum and Yamafuji (7) reported kinin formation by spleen cathepsins. Greenbaum and Kim (8) showed that poly morphonuclear leukocytes collected from peritoneal exudates of rabbits contain enzyme activity that can catalyze the formation of kinin-like material from human and bovine bradykininogen.
Back and Steger (9) demon strated that the acid proteinase kinin-forming enzyme in the lymphosarcoma most closely resembles a cathepsin. Greenbaum et al. (10) reported that the macrophages and leukemic cells contain enzymes that form kinins from kininogen substrates at acidic pH. Chang et al. (11) reported that two pharmacologically active peptides, leukokinin M and PMN, were isolated from incubates of human kininogen and enzyme fractions of macro phages and polymorphonuclear leukocytes. Greenbaum (12) showed that leukokinin M and PMN were biologically BK-like sub stances, but they do not contain BK in the crucial part of the amino acid sequence. Greenbaum et al. (13) demonstrated the release of leukokinin H from leukokininogen by cathepsin D in human ascite fluid of a patient with ovarian carcinoma. Greenbaum (14) reported that in neoplastic disease, pepstatin, an inhibitor of acid kininogenases such as cathepsin D, showed a therapeutic effect by inhibition of leukokinin release.
The KFE had characteristics similar to cathepsin D, so it was reasonable that the KFE as well as cathepsin D catalyzes the formation of kinin (leukokinin)-like sub stance.
The product from rat plasma produced by KFE was classified as a biologically BK-like substance (1) . The results of the present investigations showed that four uterine contractile substances (a, b, c and d) existed in the reaction mixture of KFE with rat plasma (Fig. 5) , therefore the pharmacological effects of the product from rat plasma by KFE in the previous paper (1) can be ascribed to the sum total of the activities of the four materials (a, b, c and d). All the materials contracted the rat uterus and relaxed the rat duodenum. The uterine-contractile activity of these materials was abolished by chymo trypsin, but not by trypsin treatment. The major material (c, 67%) produced a fall in rabbit blood pressure. The retention times of materials a, c and d on HPLC were different from that of kallidine, MLBK, BK and neuro tensin; but the retention time of material b was equal to that of BK. From these results, material c was classified as a biologically BK-like peptide which is distinct from kallidin, MLBK, BK and neurotensin. The content ratios of materials a and b both were only 4%, so materials a and b may be impurities from the KGN or KFE preparation itself derived from rat plasma, and material b seems to be BK according to its retention time on HPLC. Material d is a kinin-like peptide which is distinct from kallidin, MLBK, BK and neuro tensin from the results of HPLC. (12) . The absence of tyrosine in materials c and d distinguish materials c and d from the leukokinins. The result of the rechromatography on HPLC and the bioactive potency of the preparation containing material c suggested that material c was highly purified. We reported the existence of a BK like substance (PI) in the rat stomach (15) ; and PI is a biologically BK-like peptide which is distinct from kallidin, MLBK and BK (3, 16) . Whether or not materials a, b, c and d are equivalent to PI is the subject of ongoing investigations.
Kallikreins have marked actions on blood vessels and smooth muscles in vivo through the release of pharmacologically active pep tides, i.e., kallidin and BK (17) . It was shown that kallikreins exist in the gastrointestinal tract (18) (19) (20) (21) (22) . The dog colon kallikrein releases kallidin and BK (20) . Zeitlin (23) reported that the kinin release by kallikrein could well be one of factors controlling the normal vasomotor tone, vascular permeability and motility of the intestine. Habermann (24, 25) , Hochstrasser and Werle (26) and Guimaraes et al. (27) demonstrated that pepsin releases MLBK and its analogs from various KGN. Pepsin may be also one of the factors controlling the function of the stomach. The content of KFE and pepsin in the rat stomach is much higher than that in any region of the intestine. The kallikrein content in the rat stomach was lower than that of any other region of the alimentary tract (22, 23) . The KFE and pepsin both may function as possible substitutes in the stomach for the kallikrein, the optimum pH being 8.5.
We propose that materials c and d released by KFE as well as the kinins (MLBK and its analogs) released by pepsin in the rat stomach function as possible substitutes for the kinins (kallidin and BK) released by kallikreins.
Erspamer and Melchiorri (28) presented the concept of a skin-gut-brain peptide triangle, i.e., the various peptide families of the amphibian skin exist as their counter parts in mammalian gut and brain (29) . Materials c and d, along with the kinins generated by kallikrein and pepsin, may be possible candidates as biologically BK-like peptides in the gastro-intestinal tract.
